Fundraising Fox

Ian Tomlinson

Investor

Investor at Start Codon

Cambridge, England, United Kingdom

About

A pharma R&D leader, biotech entrepreneur and antibody engineer. He co-founded and was CSO of Domantis (sold to GSK in 2007 for $454m), later served as SVP and Head of Worldwide Business Development at GSK, and chaired Stevenage Bioscience Catalyst and Apollo Therapeutics.

LinkedIn ↗

Experience

  1. Maxion TherapeuticsChaircurrent2022 — presentCambridge, England, United Kingdom
  2. Apollo TherapeuticsFounder Director and SAB Chaircurrent2021 — presentCambridge, England, United Kingdom
  3. Apollo TherapeuticsChair2016 — 2021Stevenage, England, United Kingdom
  4. Start CodonChaircurrent2019 — presentCambridge, United Kingdom
  5. Stevenage Bioscience CatalystChair2015 — 2020Stevenage, UK
  6. GSKSenior Vice President and Head of Worldwide Business Development2011 — 2016Stevenage, England, United Kingdom
  7. GSKSenior Vice President and Head of Biopharmaceuticals R & D2008 — 2016Stevenage, England, United Kingdom
  8. GSKVP, Biopharm CEDD2007 — 2008Stevenage, England, United Kingdom
  9. DomantisCo-Founder, EVP and CSO2001 — 2007Greater Cambridge Area
  10. MRC Laboratory of Molecular Biology (LMB)Research Scientist1990 — 2001Greater Cambridge Area

Education

  1. Trinity College CambridgeJunior Research Fellow, Antibody Engineering1993 — 1997
  2. The Open UniversityDoctor of Philosophy - PhD, Antibody Gene Sequencing and Mapping1990 — 1995
  3. University of CambridgeBA, Zoology1987 — 1990

Skills & more

Management1Strategic Planning5Leadership5Strategy1Biotechnology7Research and Development (R&D)3Business Development

From Ian's professional profile.

Same school

Also attended Trinity College Cambridge2

Simon PickardAdvisor at The First ThirtyAlistair HopkinsInvestor at Inspired Gaming Group

Also attended The Open University32

Hubertus ThonhauserPartner - Chairman at Ghaf Capital PartnersRoz TurnerOperations & Support at Aera VCMalgorzata RogalskaAssociate at Ysios CapitalKate NussrainerExecutive Assistant to CEO at Founders FactoryRichard WeisfeldManaging Partner (Venionaire Capital Advisory Services) at Venionaire CapitalBrendon GrunewaldGrowth – Data Sovereignity – Finance at Angelwise

+ 26 more

Also attended University of Cambridge621

Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)Nic LowdenInvestor at Moonfire Ventures

+ 615 more

Shared employers

Also worked at Maxion Therapeutics3

Tim FunnellPartner at Monograph Capital PartnersMelisa GuvenInvestment Manager at Monograph Capital PartnersJonathan NashInvestment Principal at LifeArc Ventures

Also worked at Apollo Therapeutics1

Fiona MacLaughlinVice President, Venture Investments at Johnson & Johnson Innovation – JJDC

Also worked at Stevenage Bioscience Catalyst1

Clare TerlouwManaging Partner / Head of LifeArc Ventures at LifeArc Ventures

Also worked at GSK101

Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal at AlleyCorpCarol SuhPartner at ARCH Venture Partners

+ 95 more

Colleagues at Start Codon

Ian
Investor at Start Codon